Last edition
News about "tyrosine kinase inhibitor "
HUTCHMED, AstraZeneca Submit US NDA for Orpathys-Tagrisso Combination
AstraZeneca submits a US FDA NDA for Orpathys plus Tagrisso in MET-driven NSCLC following EGFR-TKI progression, supported by positive Phase 3 SAFFRON PFS and OS results.
Tyrosine Kinase Inhibitor | 01/10/2026 | By News Bureau | 112
Merck Completes USD 5.8 Billion Acquisition of Terns Pharmaceuticals to Strengthen Oncology Pipeline
Merck acquires Terns Pharmaceuticals, advancing development of next-generation therapies for chronic myeloid leukaemia.
Tyrosine Kinase Inhibitor | 06/05/2026 | By News Bureau | 175
Innovent Partners with Ask Pharm for Limertinib for Treatment of Lung Cancer
Under the agreement, Innovent will obtain the exclusive commercialization rights for limertinib in mainland China, and will be entitled to receive a commercialization service fee based on the product's net sales in the region.
Tyrosine Kinase Inhibitor | 08/10/2024 | By Aishwarya | 668
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy